Healing
Thymosin Beta-4
Longevity
37
Amino acids
Molecular weight
Peptide
Type
Naturally occurring 43-amino acid peptide crucial for tissue repair, wound healing, and cellular regeneration. Promotes angiogenesis, reduces inflammation, and supports cell migration and differentiation.
Top researched benefits
Overview of Thymosin Beta-4
Direct systemic delivery provides optimal bioavailability and distribution to target tissues for comprehensive regenerative effects including angiogenesis, cell migration, and differentiation.
Tissue Repair
- Clinical trials show 67% complete healing versus 25% placebo in pressure ulcers.
- Enhanced tissue regeneration and reduced healing time in surgical wounds.
- Accelerated recovery in muscle, tendon, and ligament injuries.
Cardiovascular
- Phase 2b trials show 43% reduction in infarct size when given within 6 hours.
Neuroprotection
- Improved neurological outcomes and functional recovery in animal models.
Storage
Reconstituted: 2-8°C, use within 14 days
Frequency
Daily for acute healing, 2x weekly for maintenance/chronic conditions
Typical Dose
2-6mg per injection (varies by protocol and severity)
Cycle Duration
2-12 weeks depending on healing needs
Chemical Makeup
Key benefits
Systemic regenerative effects
Proven clinical efficacy
Optimal bioavailability for tissue repair
Promotes angiogenesis
Reduces inflammation
Community interest
This peptide is still gaining traction in the community.
43-Amino Acid Regenerative Peptide | Tissue Repair & Healing
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesThymosin Beta-4 Molecular Information
View the scientifc details of Thymosin Beta-4.
37
Amino Acids
Thymosin Beta-4
Lys
Lys
Position 1
Trp
Trp
Position 2
Lys
Lys
Position 3
Leu
Leu
Position 4
Phe
Phe
Position 5
Lys
Lys
Position 6
Lys
Lys
Position 7
Ile
Ile
Position 8
Glu
Glu
Position 9
Lys
Lys
Position 10
Val
Val
Position 11
Gly
Gly
Position 12
Gln
Gln
Position 13
Asn
Asn
Position 14
Ile
Ile
Position 15
Arg
Arg
Position 16
Asp
Asp
Position 17
Gly
Gly
Position 18
Ile
Ile
Position 19
Ile
Ile
Position 20
Lys
Lys
Position 21
Ala
Ala
Position 22
Gly
Gly
Position 23
Pro
Pro
Position 24
Ala
Ala
Position 25
Val
Val
Position 26
Ala
Ala
Position 27
Val
Val
Position 28
Val
Val
Position 29
Gly
Gly
Position 30
Gln
Gln
Position 31
Ala
Ala
Position 32
Thr
Thr
Position 33
Gln
Gln
Position 34
Ile
Ile
Position 35
Ala
Ala
Position 36
Lys
Lys
Position 37
Molecular Weight
4004DaChain Length
37Amino AcidsType
PeptideThymosin Beta-4 Protocols
Systemic regenerative effects with proven clinical efficacy and optimal bioavailability.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Acute Wound Healing | 1.6 | 1 week range | SubQ |
| Cardiac Protection | 42 | — | IV bolus within 6 hours of MI |
| Chronic Tissue Repair | 6 | 2 week range | SubQ |
| Neurological Recovery | 30 | 72 week range | IV infusion |
| General Regeneration | 2 | 1 week range | SubQ |
Reconstitution Instructions
Materials needed:
Steps to reconstitute
- Allow lyophilized powder to reach room temperature before reconstitution
- Add bacteriostatic water slowly to vial wall, avoiding direct powder contact
- Gently swirl (do not shake vigorously) until completely dissolved
- Inspect solution for clarity—should be clear and colorless
- Store reconstituted solution at 2-8°C and use within 14 days
- Use proper aseptic technique and rotate injection sites
Thymosin Beta-4 Cycle
The Thymosin Beta-4 Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
- Week 1-2
- Initial tissue response, possible mild injection site reactions
- Week 2-4
- Accelerated healing becomes apparent, reduced inflammation
- Week 4-8
- Significant tissue regeneration and functional improvement
- Week 8-12
- Sustained benefits and near-complete healing in responsive conditions
Dosing tools
Thymosin Beta-4 Peptide Dosage Calculator
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Injection Results
Based on your vial and dilution inputs.
Safe concentration range
Thymosin Beta-4
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Thymosin Beta-4 vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Reference Guide
Dosing Cycle
- Peptide
- Thymosin Beta-4
- Dosing
- 2-6mg per injection (varies by protocol and severity)
- Dosing Frequency
- Daily for acute healing, 2x weekly for maintenance/chronic conditions
- Cycle Duration
- 2-12 weeks depending on healing needs
- Storage
- Reconstituted: 2-8°C, use within 14 days
Note: Triple agonist; microdose for fewer side effects
Reconstitution Tips
- Use bacteriostatic water (BAC) — contains 0.9% benzyl alcohol for preservation
- Inject water slowly — aim down the vial wall, not directly onto powder
- Never shake — gently swirl or roll the vial until dissolved
- Store properly — refrigerate at 2-8°C after reconstitution
- Use within 28 days — most reconstituted peptides remain stable for about 4 weeks
- Keep sterile — always clean vial tops with alcohol before drawing
Peptide Interactions
Research suggestions of Thymosin Beta-4 interactions with other common peptides and substances.
Healing
bpc
Longevity
BPC-157
SYNERGISTIC
Complementary healing mechanisms—Tβ4 promotes cell migration and angiogenesis while BPC-157 enhances gastric protection.
Healing
tb5
Longevity
TB-500
SYNERGISTIC
TB-500 is the bioactive fragment of Thymosin β4. Combined use provides full-length peptide benefits plus concentrated bioactive effects.
Side effects
Contraindications
Active chemotherapy treatment
Severe systemic allergies to peptides
Stop signs
Severe injection site reactions or persistent inflammation
Signs of systemic allergic reaction (rash, breathing difficulty)
Unexpected cardiovascular symptoms during treatment
Any signs of infection at injection sites
Bad signs
Comments
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Frequently asked questions
What benefits can peptides offer in research?
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
What are some exciting applications of peptides in modern science?
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
How do peptides influence health and wellness?
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Where can I find the latest studies on peptide applications?
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Are there any guidelines for using peptides in research?
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
What is the difference between peptides and proteins?
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
How should peptides be stored?
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Can peptides be taken orally?
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
Thymosin Beta-4Research References
Thymosin Beta-4 is a well studied compound
Thymosin Beta-4
Thymosin Beta-4 is a well studied compound
Phase II Dry Eye Clinical Trial
72 subjects showing significant positive effects on ocular discomfort and corneal staining with excellent safety profile.
2015
Phase I Human Safety Study: Intravenous Thymosin β4
First-in-human study establishing safety and pharmacokinetics in healthy volunteers with no dose-limiting toxicity.
2010
Cardiac Protection Pilot Study: Thymosin β4 in STEMI Patients
First human study in heart attack patients demonstrating potential clinical benefits in repairing damaged tissue.
2016
Neurotrophic Keratopathy Compassionate Use Trial
Complete clearing of persistent corneal defects in most subjects using topical formulation.
2010